The Open Project of Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Gannan Medical University, Ganzhou, P.R. of China.
Department of Cardiology, Affiliated Ganzhou City Hospital, Nanchang Medical University, Ganzhou, P.R. of China.
Clin Exp Hypertens. 2021 Nov 17;43(8):699-706. doi: 10.1080/10641963.2021.1945075. Epub 2021 Jun 28.
: Hypertension is associated with a low-grade systemic inflammation in cardiovascular system. Macrophage infiltration may initiate an inflammatory process that contributes to vascular and ventricular remodeling in hypertensive human and mice. The present study investigated the effect of chemical depletion of macrophage using liposome encapsulated clodronate (LEC) on cardiac hypertrophy and remodeling in angiotensin (Ang) II hypertensive mice.: C57BL/6 mice received an Ang II (1.1 mg/kg/day with a minipump) infusion for 2 weeks to induce hypertension. Endothelium-dependent relaxation (ED) was examined by organ bath, hematoxylin and staining and Masson-Trichrome staining were used to evaluate aorta and cardiac hypertrophy and fibrosis.: Ang II infusion significantly increased systolic blood pressure (SBP), cardiac hypertrophy and fibrosis, and impaired EDR accompanied by increased macrophage infiltration in the heart. Treatment with LEC significantly lowered Ang II-induced cardiac hypertrophy and fibrosis and cardiac macrophage infiltration, and improved EDR with a mild reduction in SBP. Ang II increased the expression of inflammatory cytokines tumor necross factor alpha and interleukin 1 beta and profibrotic factors transforming growth factor beta 1 and fibronectin in the heart, with was reduced by LEC treatment. Treatment with LEC prevented Ang II-induced the phosphorphorylation of ERK1/2 and c-Jun-N-terminal kinase.: Our study suggests that cardiac macrophage may be critical for hypertensive cardiac hypertrophy and remodeling, the underlying mechanisms may involve initial heart inflammation and the activation of hypertrophic MAPKs pathway.
高血压与心血管系统的低度全身炎症有关。巨噬细胞浸润可能启动炎症过程,导致高血压患者和小鼠的血管和心室重构。本研究探讨了使用脂质体包裹的氯膦酸盐(LEC)化学耗竭巨噬细胞对血管紧张素(Ang)II 高血压小鼠心脏肥大和重构的影响。C57BL/6 小鼠接受 Ang II(1.1 mg/kg/天,通过微泵输注)输注 2 周以诱导高血压。通过器官浴、苏木精和伊红染色以及 Masson-Trichrome 染色评估主动脉和心脏肥大和纤维化,评估内皮依赖性松弛(EDR)。Ang II 输注显著增加收缩压(SBP)、心脏肥大和纤维化,并损害 EDR,伴有心脏巨噬细胞浸润增加。LEC 治疗显著降低了 Ang II 诱导的心脏肥大和纤维化以及心脏巨噬细胞浸润,并改善了 EDR,同时轻度降低了 SBP。Ang II 增加了心脏中炎症细胞因子肿瘤坏死因子-α和白细胞介素 1β以及促纤维化因子转化生长因子-β1 和纤维连接蛋白的表达,LEC 治疗降低了这些表达。LEC 治疗可预防 Ang II 诱导的 ERK1/2 和 c-Jun-N 末端激酶的磷酸化。本研究表明,心脏巨噬细胞可能对高血压性心脏肥大和重构至关重要,其潜在机制可能涉及初始心脏炎症和肥大 MAPKs 通路的激活。